retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastická činidla - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
resical 1,8mmol/g prášek pro perorální/rektální suspenzi
fresenius medical care nephrologica deutschland gmbh, bad homburg array - 3488 kalcium-polystyrensulfonÁt - prášek pro perorální/rektální suspenzi - 1,8mmol/g - polystyren-sulfonÁt